Senior Director, Business Development @ Cubist Pharmaceuticals (July 2011 - July 2013)
Director, Corporate Development @ Cubist Pharmaceuticals (August 2008 - June 2011)
Senior Manager, Business Development @ Cubist Pharmaceuticals (November 2005 - July 2008)
Manager, Decision Support @ Cubist Pharmaceuticals (June 2004 - October 2005)
Senior Sales Analyst @ (October 2002 - June 2004)
Marketing Intern @ (May 2001 - August 2001)
Engineer @ Gamera Bioscience (January 1998 - January 2000)
Process Engineer @ (June 1996 - June 1998)
Aaron Pelta Education
The Tuck School of Business at Dartmouth
MBA
2000-2002
Tufts University
BS (Chemical Engineering)
1992-1996
Aaron Pelta Skills
Biopharmaceuticals
Biotechnology
Business Development
Business Strategy
Clinical Development
Clinical Trials
Commercial Analytics
Commercial Operation
Commercialization
Corporate Development
Cross-functional Team Leadership
Drug Development
Due Diligence
Forecasting
Gastroenterology
Healthcare
Hospital Sales
Hospitals
Infectious Diseases
Licensing
Licensing Agreements
Life Sciences
Lifesciences
Management
Market Analysis
Market Research
Marketing
Mergers
Mergers & Acquisitions
Pharmaceutical Industry
Pharmaceutical Sales
Pharmaceutics
Product Launch
Sales Operations
Strategic Planning
Strategy
Technology Transfer
Leadership
Engineering
Java
Cross Functional Team Leadership
JavaScript
Mergers and Acquisitions
Social Media
Sales
Testing
Process Improvement
Aaron Pelta Summary
Aaron Pelta, based in Boston, MA, US, is currently a Co-Founder and Chief Business Officer at Caldera Therapeutics. Aaron Pelta brings experience from previous roles at Morphic Therapeutic, Arsanis and Shire. Aaron Pelta holds a 2000 - 2002 MBA @ The Tuck School of Business at Dartmouth. With a robust skill set that includes Biopharmaceuticals, Biotechnology, Business Development, Business Strategy, Clinical Development and more. Aaron Pelta has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Aaron Pelta?
Find contact details for 700 million professionals.